IRISanRaf

CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.844
NA - Nord America 1.149
SA - Sud America 699
EU - Europa 138
AF - Africa 46
OC - Oceania 12
Totale 4.888
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 2.385
US - Stati Uniti d'America 1.093
BR - Brasile 524
VN - Vietnam 304
AR - Argentina 71
HK - Hong Kong 42
EC - Ecuador 41
MX - Messico 34
ID - Indonesia 32
DE - Germania 30
IT - Italia 27
CO - Colombia 21
ZA - Sudafrica 21
BD - Bangladesh 18
CA - Canada 17
GB - Regno Unito 15
CL - Cile 13
IN - India 13
RU - Federazione Russa 12
PL - Polonia 11
PY - Paraguay 10
IQ - Iraq 9
UA - Ucraina 9
IE - Irlanda 8
AU - Australia 7
PE - Perù 7
VE - Venezuela 7
AT - Austria 6
EG - Egitto 6
NZ - Nuova Zelanda 5
AL - Albania 4
CN - Cina 4
JP - Giappone 4
NP - Nepal 4
PK - Pakistan 4
UY - Uruguay 4
AO - Angola 3
CR - Costa Rica 3
KZ - Kazakistan 3
MA - Marocco 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
DZ - Algeria 2
EE - Estonia 2
FR - Francia 2
KR - Corea 2
NL - Olanda 2
SA - Arabia Saudita 2
TR - Turchia 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
ES - Italia 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
PT - Portogallo 1
RS - Serbia 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
Totale 4.888
Salva come PNG Salva come JPEG
Città #
Dallas 946
Singapore 175
Ho Chi Minh City 114
Hanoi 59
São Paulo 49
Hong Kong 40
Mexico City 22
Ashburn 16
Munich 16
Quito 15
Rio de Janeiro 14
Guayaquil 13
Haiphong 12
Johannesburg 11
Thái Bình 11
Biên Hòa 10
Brasília 10
Los Angeles 10
Manaus 10
New York 10
Frankfurt am Main 9
Hải Dương 9
Belo Horizonte 8
Bogotá 8
Da Nang 8
Warsaw 8
Brooklyn 7
Bắc Giang 7
Can Tho 7
Curitiba 7
Duque de Caxias 7
Naples 7
Porto Alegre 7
Santiago 7
Dhaka 6
Dublin 6
Guarulhos 6
Jakarta 6
Joinville 6
Montreal 6
Ninh Bình 6
São José 6
Bauru 5
Bắc Ninh 5
Chennai 5
Goiânia 5
Lima 5
Quảng Ngãi 5
Recife 5
San Francisco 5
Santa Clara 5
Sorocaba 5
São Bernardo do Campo 5
Boardman 4
Boston 4
Buenos Aires 4
Campinas 4
Canoas 4
Chicago 4
Fortaleza 4
Petrópolis 4
Santo André 4
Suzano 4
Vienna 4
Auckland 3
Beijing 3
Bà Rịa–Vũng Tàu Province 3
Cape Town 3
Caracas 3
Catanduva 3
Caxias do Sul 3
Ciudad del Este 3
Cotia 3
Ha Long 3
Hortolândia 3
Huế 3
Jaboatão dos Guararapes 3
Jacareí 3
Macaé 3
Maricá 3
Medellín 3
Melbourne 3
Monte Grande 3
Montevideo 3
Natal 3
Nuremberg 3
Okayama 3
Piraquara 3
Quilicura 3
Quilmes 3
Quảng Ninh 3
Quận Một 3
Salvador 3
San Fernando 3
São Sebastião do Paraíso 3
Tashkent 3
Thái Nguyên 3
Toronto 3
Vinhedo 3
Amsterdam 2
Totale 1.923
Salva come PNG Salva come JPEG
Nome #
Advances in Nanomedicine for Precision Insulin Delivery 219
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 216
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 214
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 211
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 210
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 210
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 210
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 209
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 209
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 203
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 189
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 181
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 172
Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition 154
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 146
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 105
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 45
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 44
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 43
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 37
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 32
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 32
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 30
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 29
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 28
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 28
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 27
Advancements in Cardiovascular and Antidiabetic Drug Therapy 26
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 26
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 25
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 25
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 25
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 24
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 24
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 24
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 23
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 23
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 23
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 23
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 23
HCC and molecular targeting therapies: Back to the future 23
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 23
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 23
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 23
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 23
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 22
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 22
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 22
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 22
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 22
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 22
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 22
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 22
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 22
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 21
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 21
Rethinking the Diabetes–Cardiovascular Disease Continuum: Toward Integrated Care 21
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 21
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 21
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 20
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 20
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 20
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 20
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 20
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 20
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 20
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 20
Post-fracture thromboprophylaxis: is it time for a change? 20
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 20
Insulin resistance and cancer: molecular links and clinical perspectives 20
Sarcopenic obesity and weight loss-induced muscle mass loss 19
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 19
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 19
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 19
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 19
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 19
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 19
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study 19
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 18
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 18
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 18
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 18
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 18
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 18
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 18
Impact of Empagliflozin as add-on to Metformin vs Metformin continuation on MASLD Progression in Type 2 Diabetes: The IMAGIN Study 17
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 17
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 17
Comment on: Prevalence of micro and macro vascular complications and their risk factors in type 2 diabetes in saudi arabian population: An analysis from shis 17
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 16
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 16
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo 15
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 15
Predictive value of Shanghai score system in patients with drug-induced type 1 Brugada electrocardiographic pattern 15
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 15
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 15
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 14
Brugada syndrome and COVID-19 vaccines 12
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 11
High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study 11
Totale 4.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/20262.424 192 361 1.381 490 0 0 0 0 0 0 0 0
Totale 5.017